Skip to main content
Clinical Trials/NCT00868920
NCT00868920
Completed
Not Applicable

A Phase IV, Randomized, Double-Blind, Controlled Study of the Effects of Patient-Controlled Sedation vs. Anesthesiologist-Administered Sedation With Propofol and Remifentanil on Rate of Disordered Breathing in Subjects Undergoing Elective Colonoscopy

University of Pennsylvania1 site in 1 country50 target enrollmentJanuary 2008
ConditionsColonoscopy

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Colonoscopy
Sponsor
University of Pennsylvania
Enrollment
50
Locations
1
Primary Endpoint
The primary outcome measure is the depth of sedation,
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

The purpose of this study is to see whether patients controlling their own sedation during colonoscopy are less likely to need help breathing than when an anesthesiologist controls the medicine, and whether we can predict when the need for help will occur. The pump used in the study is approved for clinical use by the FDA, as are the medicines used in the pump.

Registry
clinicaltrials.gov
Start Date
January 2008
End Date
March 2009
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Undergoing elective, outpatient colonoscopy
  • Age ≥ 18, \<90
  • Meet criteria for conscious sedation (HUP Policy 1-12-11, Appendix F), as determined by the attending gastroenterologist and confirmed by the anesthesiologist by review of history
  • Able to give informed consent

Exclusion Criteria

  • Have a history of allergy or adverse reaction to propofol or remifentanil
  • Have a condition which would pose an elevated risk for administration of propofol, including primary hyperlipoproteinemia, diabetic hyperlipemia, and pancreatitis.
  • Female of child-bearing potential (under 50 without surgical sterilization)
  • Unable to understand the use of Patient Contolled Sedation

Outcomes

Primary Outcomes

The primary outcome measure is the depth of sedation,

Time Frame: during colonoscopy procedure

Secondary Outcomes

  • The secondary outcome measure is rate of respiratory depression(during colonoscopy procedure)

Study Sites (1)

Loading locations...

Similar Trials